| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f992557ac5e62ff7183f613ffb8dfa45 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-306
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-31
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2803
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-605
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-18 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-605
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 |
| filingDate |
2021-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7b6f544a31947791fa9439033426fbe9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6f3b647b572c3dca90946333486fd284
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b5ccca73b18f5b4d5e9c56345b76ee26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_76bdfe06b9dfa6317ce7adb4e695a0e0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e424af37019b1bda198f002af061dcd0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_665a6d00de7d144227a6e3247a609efd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_32e44ba88f98e674f7a87041170bd865
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7a68f6c2e9dbfa2b724904f5973211a2 |
| publicationDate |
2022-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2022119076-A1 |
| titleOfInvention |
Fusion protein including glp-1 receptor agonist and anti-oscar antibody, and use thereof |
| abstract |
The present invention relates to: a fusion protein including a glucagon like peptide-1 (GLP-1) receptor agonist and an anti-osteoclast-associated receptor (OSCAR) antibody; a pharmaceutical composition for preventing or treating arthritis, comprising the fusion protein; a food composition; a health functional composition; and a method for preventing or treating arthritis, comprising a step of administering the pharmaceutical composition. The fusion protein including a GLP-1 receptor agonist and an anti-OSCAR antibody of the present invention has excellent effects of cartilage protection and pain relief, and thus can be widely used in the effective treatment of arthritis. |
| priorityDate |
2020-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |